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Abstract?On?June?22,?2012?the?First?Symposium?of?Ichthyosis?Experts?in?Spain?was?held?at?the?
Hospital?Ni˜no?de?Jesús?in?Madrid.?It?was?a?one-day?symposium?for?dermatologists,?
pediatricians,?and?physicians-in-training?interested?in?this?disease,?as?well?as?for?other?health?
care?profes-sionals?involved?in?the?care?of?patients?with?ichthyosis.?The?aim?of?the?meeting?
was?to?try?to?structure?the?care?of?ichthyosis?patients?in?Spain.?As?happens?in?other?rare?
diseases,?because?of?the?low?prevalence?of?ichthyosis?and?the?absence?of?designated?referral?erma centers,?the?number?of?patients?treated?in?each?center?is?very?low?and?few?dermatologists?
have?any?real?clinical?experience?with?this?condition?or?know?how?to?order?diagnostic?genetic?
tests.?This?article?sum-marizes?the?presentations?given?at?the?symposium?and?is?intended?as?a?
reference?for?anyone?interested?in?the?subject.
nding author.
ddress:?ahernandez?hnj@yahoo.es?(A.?Hernández-Martín).
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I?Jornada?de?expertos?en?ictiosis
Resumen?El?día?22?de?junio?de?2012?se?celebró?en?el?Hospital?Ni˜no?Jesús?la?I?Jornada?de?
expertos?en? ictiosis,?una? jornada?monográfica?dirigida?a?dermatólogos,?pediatras?y?médicos?
en?formación? interesados?en?esta?enfermedad,?así?como?al?resto?de?profesionales?sanitarios?
que?participan?en?su?atención.?El?objetivo?de? la? l?Jornada?de?expertos?en? ictiosis?fue? inten-
tar?estructurar?la?atención?de?los?pacientes?con?ictiosis?en?Espan˜a.?Como?ocurre?con?el?resto?
de?las?enfermedades?raras,?su?escasa?prevalencia?y?la?ausencia?de?centros?de?referencia?for-
males?diluyen?el?número?de?pacientes?atendidos?en?cada?centro,?y?pocos?dermatólogos?tienen?
verdadera?experiencia?clínica?o?conocen?la?manera?de?solicitar?diagnóstico?genético.?En?este?
uesta
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is is the collective name for a group of inherited
f keratinization characterized by the presence
ratosis and/or scaling. Despite the similarity of
l presentation of some of these disorders, each
result of a specific genetic abnormality and the
pattern is Mendelian. As there is no definitive
ese disorders and management of the symptoms
difficult, ichthyoses have a significant impact on
ves and the dynamics of their families.
t Symposium of Ichthyosis Experts in Spain was
e 22, 2012 in the Hospital Nin˜o Jesús in Madrid.
one-day symposium for dermatologists, pediatri-
physicians-in-training interested in this disease,
or other health care professionals involved in the
tients with ichthyosis. The symposium program
resentations by experts in the diagnosis, treat-
care of patients with ichthyosis and by members
rd of the Spanish Ichthyosis Association (ASIC).
was supported by the European Together Against
tosis (TAG) network and received financial and
nal support from Pierre Fabre Laboratories Inter-
d its Spanish subsidiary.
of the First Symposium of Ichthyosis Experts
to structure the care of ichthyosis patients in
appens in other rare diseases, because of the
nce of ichthyosis and the absence of designated
nters, the number of patients treated in each
ry low and few dermatologists have any real clin-
ence with this condition or are familiar with the
for ordering diagnostic genetic tests. This article
s the presentations made at the conference for
ation of those interested in the subject.
?of?Presentations
g remarks were made by Dr. Antonio Torrelo, head
atology department in the Hospital Nin˜o Jesús,
ela Hernández, staff dermatologist in the same
d symposium coordinator. The day’s program
d into 4 parts: the first part mainly clinical (Dr.
, Dr. de Lucas, Dr. Torrelo and Dr. Casco); a sec-
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ysiology?of?Keratinization?Disorders
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enerally accepted biological model describes the
as a wall in which the bricks are keratinocytes
ement that binds them together is the inter-
bstance. Keratinization is a process involving a
ructural and metabolic changes in keratinocytes
at the basal layer of the epidermis (the inner-
of basal keratinocytes) and continues up to the
rneum (the outermost epidermal layer, composed
ytes). Corneocytes are cells without nuclei and
they are enclosed in an external envelope (the
nvelope) and contain keratin filaments encased
n matrix. The keratin filaments are specific to
and the degree of cell differentiation, varying
o the epidermal stratum where they are located
sue type (specific keratins exist for nails, hair,
mbranes, and skin). The protein matrix is essen-
osed of filaggrin, a histidine-rich protein whose
s profilaggrin. In addition to these structural pro-
are others having enzymatic activity, such as
transglutaminase, an enzyme that promotes the
the cornified envelope by establishing covalent
een the structural proteins. The intercellular
mainly lipid, controls intercellular permeabil-
odulates flaking by way of lipases, proteases,
se inhibitors. Our evolving understanding of the
ology of ichthyosis is making it possible for us to
effect of each biomolecular abnormality on kera-
nd the associated clinical manifestations in each
aneous?Manifestations?of?Ichthyosis
io Torrelo. Head of the Dermatology
nt of the Hospital Infantil Nin˜o Jesús,utaneous manifestations of ichthyosis can be
the skin disorder itself or by a homeostatic
secondary to impaired epidermal barrier func-
can also be the result of genetic abnormalities
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ypeother organs, as is the case of the syndromic
. Ichthyosis can affect any cutaneous tissue,
he mucous membranes and skin adnexa. Thus, it is
mon for patients to present ectropion or eclabium
periorificial retraction, keratitis secondary to the
or to friction with scales, hearing loss due to
caling in the external auditory canal, dysphonia
atinization of the vocal cords, hypotrichosis, nail
or hypohidrosis. In neonates, epidermal barrier
pairment is not only severe in certain rare forms
sis, such as Netherton syndrome and harlequin
but also in collodion babies. The syndromic
can be associated with severe abnormalities
m the underlying genetic disorder. Some of these,
sum syndrome and neutral lipid storage disease,
l. Others are associated with significant morbidity
neurological involvement (Sjögren-Larsson syn-
DNIK [mental retardation, enteropathy, deafness,
, ichthyosis, keratodermia] syndrome, CEDNIK
dysgenesis, neuropathy, ichthyosis, and palmo-
atoderma] syndrome), musculoskeletal disorders
splasia punctata), sensorineural deafness and
KID, that is, keratitis, ichthyosis and deafness,
, or mental retardation (trichothiodystrophy).
f patients with ichthyosis requires a multidis-
pproach and their treatment must be properly
y the dermatologist.
ical?Classification?of?the?Ichthyoses
e Lucas. Head of Pediatric Dermatology
spital Universitario La Paz, Madrid
2010, the Journal of the American Academy
ology published a new consensus statement
ssification of ichthyoses, which has proved to
of extraordinary clinical utility.1 In total, 36
ypes of ichthyosis, some very rare, are cur-
ded in the classification. This new classification
nternational consensus on ichthyosis nomencla-
ed to the elimination of terms such as bullous
ichthyosiform erythroderma and epidermolytic
osis, both of which referred to the same dis-
ichthyoses are divided into subgroups according
requency, the Mendelian inheritance pattern,
ing to whether they are associated with extra-
signs or not (syndromic and non-syndromic
respectively). Ichthyosis vulgaris and nonsyn-
linked ichthyosis are the only common forms
ease. The group of nonsyndromic ichthyoses
he autosomal recessive congenital ichthyoses
the keratinopathic ichthyoses. The umbrella
efers to lamellar ichthyosis, harlequin ichthyosis,
congenital ichthyosiform erythroderma (and
ediate spectrum), generalized and acral self-
llodion baby, and bathing suit ichthyosis. The
organ
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nominated bullous congenital erythrodermas or
tic hyperkeratosis, which are now called epider-
thyosis. The syndromic ichthyoses are classified
groups according to mode of inheritance, the
or K10 kera
correlation
are involve
(TGM1, AL
ABCA12).
?lly affected (hair, nervous system), fatal dis-
e, and other signs (a miscellaneous group).
fication may change in the future when as
wn biomolecular aspects are elucidated, but
ultation of this recent classification is essen-
understanding of the disease and the correct
f these patients because it enumerates the clin-
ogic, and molecular features of each type of
istologic?Diagnosis?in?Ichthyosis
ndo Casco. Pathologist at the Hospital
niversitario Nin˜o Jesús, Madrid
gic study of ichthyoses requires careful correla-
clinical and histopathological findings because
ngs alone are not specific. In most cases, his-
reveal hyperkeratosis, irregular acanthosis, and
sodilatation, findings consistent with a diagno-
(formerly nonbullous congenital ichthyosiform
ma), the most common clinical form. Despite
e lack of specificity, histology can sometimes
ormation that can support or rule out a diag-
example, the absence of a granular layer is a
racteristic of ichthyosis vulgaris and one that
in case of doubt, to distinguish this disease
ed ichthyosis, a disorder in which the granular
mal. In other cases, the presence of microscopic
d acantholytic fissures may orient the diagno-
s epidermolytic ichthyosis even when there is
disruption of the epidermis. There is no doubt,
hat clinical findings (and above all the results of
ar studies) are essential for the accurate diagno-
yosis. Electron microscopy is another useful tool
ements conventional microscopy; however, it is
le in most Spanish hospitals, the equipment is
and interpretation of the results requires exper-
Diagnosis?of?Ichthyosis
Rogelio González Sarmiento. Unidad de
Molecular, Departamento de Medicina e
e Biología Molecular y Celular del
niversidad de Salamanca
genome is composed of 3 billion nucleotides,
wer than 10% form genes that encode proteins.
in disorders are caused by mutations in a single
ogenic), mutations in different genes can also
imilar phenotypes (polygenic). In ichthyosis,
e of monogenic inheritance is epidermolytic
a group of conditions with a constant genotype-
relationship due in all cases to mutations in K1
tins. By contrast, this close genotype-phenotype
is not present in the ARCI and at least 7 genes
d in the pathogenesis of this group of disorders
OXE3, ALOX12B, NIPAL4, PNPLA1, CYP4F22, and
Today, the genetic mutations responsible for
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ing morms of ichthyosis have been identified and, for-
r our patients, both our own laboratory and other
oratories can provide a precise genetic diagnosis
ne the molecular abnormality responsible for the
type. In the future it will be possible to treat the
defect and to determine before birth whether
f a carrier family will have the disease. However,
re still finding cases in which the precise molec-
has not yet been identified we must continue
tients with these disorders to identify additional
normalities. To obtain more information about
sting for patients with any type of ichthyosis,
ogelio González Sarmiento (gonzalez@usal.
ega. Fundación Pública Galega de
Xenómica-Servicio Gallego de Salud,
Medicina Xenómica-Universidad de
de Compostela, Centro de Investigación
Enfermedades Raras, Instituto de
ión Sanitaria, Santiago de Compostela
egan 5 years ago with a clinical and genetic study
with ARCI in Galicia. The DNA study involved the
point mutations in the TGM1, ALOXE3, ALOX12B,
CYP4F22 genes. We identified mutations in 12 of
ilies in the study: 11 in TGM1 and 1 in ALOXE3.2
ilies had the same mutation in the TGM1 gene,
f them were homozygous. These findings led us to
aplotype study, which confirmed the presence of
tations in our population. The Fundación Ramón
ntly granted us funding to study the genetic and
racterization of Spanish patients with ARCI. One
ectives is to identify all Spanish patients with
ion and recruit them to the study. The projects’
tives include characterizing the clinical features
ses, analyzing the genes identified to date and,
latest technologies, identifying new genes that
volved in the disease and establishing genotype-
correlations. This is a multicenter project open to
ho are interested in participating. Please contact
llowing email addresses: ana.vega@usc.es, mgi-
dv.es, ladrizos@hotmail.com and Laura Fachal
al@usc.es).
idisciplinary?Approach?in?Ichthyosis:
gical?Care
uis Pedreira Massa. Staff Psychiatrist.
nfantil Nin˜o Jesús, Madrid
the system of the human body most closely con-
how we relate to others because it constitutes
card and our visible identity. In medicine, it is
isible system and the organ most often examined
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ssociated with failures and inadequacies in the
on of the self. In ichthyosis, the patient’s experi-
the disease will be greatly influenced by factors
trolyte bal
the applica
thenol and
course dep
type of ich
?the patient and his or her family as well as by
t they receive from the health care system. How-
neral, the greater the visibility and awareness
ic disease, the greater will be the effort made
ients, families, and society to adapt. Patients
amilies will also be more likely to receive the
health care support they need. As is the case
genetic diseases, in ichthyosis the information
y medical professionals is crucial in helping fam-
nds to adapt to the situation. It may be the first
n received by the family (many of whom may not
rior knowledge or a family history of the dis-
an serve to counteract the pressure within the
the family circle to find a guilty party and it can
uce their disorientation when they interact with
professionals. How well those affected will cope
first encounter with the disease will be deter-
he language used to ensure that they understand
on and its implications, the impact of the reve-
the proposal of realistic solutions and possible
entive measures. They will also need continued
help them adapt to the new circumstances; this
ppropriate to the different phases of the disease
ed not only at caring for the patient’s mental
also for that of the parents, healthy siblings, and
?Baby?and?Congenital?Erythroderma:
anagement?and?Course
Heiko Traupe. Professor of Dermatology.
of Muenster, Germany
first weeks or months after birth, the life of an
ichthyosis may be threatened by severe impair-
e epidermal barrier. Harlequin ichthyosis poses
rious threat during this period and in such cases
e is often fatal. The collodion baby is a presen-
mon to various types of ichthyosis: at birth the
encased in a shiny transparent sheath, which
limits joint mobility. The most common sys-
lems affecting the collodion baby include intense
rmal water loss (TEWL) and varying degrees of
ia and hypernatremic dehydration. These infants
aced in an incubator and they require a humid
nt, at least initially. Emollients with a high lipid
applied to maintain skin moisture. Eclabium and
an be severe and require particular attention. In
, the course is favorable, but fatal complications
p to 10% of these patients. In other cases the
e born with severe erythroderma in which the
ry component is greater than the desquamative
forms include Netherton syndrome, peeling skin
and chondrodysplasia punctata. In addition to
easures aimed at maintaining the hydroelec-ance, erythrodermic patients also benefit from
tion of creams containing glycerol and dexpan-
oil-based products in general. The long-term
ends on the genetic mutation responsible for each
thyosis.
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y of Muenster, Germany
pment of hyperkeratosis in ichthyosis not only
the genetic disorder responsible for the condi-
ch case, but also on the body’s homeostatic
which triggers epidermal hyperproliferation to
e for TEWL. To date the only treatment options
e oral and topical therapies that alleviate hyper-
r facilitate the temporary removal of excess skin.
widely used products include emollients----such
xy acid creams, urea, lactic acid, glycerol,
nthenol----some of which also have a keratolytic
application of salicylic acid and white petrola-
ent is not recommended because of the danger
lic acidosis when this product is applied on
s or in newborn infants. Patients with lamellar
require a long daily bath, mechanical removal
including those in the external auditory canal),
plication of topical products at least twice a day.
e added to the bath water appears to promote
, probably because it destabilized the intercel-
ions. The daily application of topical products is
ming and the products used often stain cloth-
inconveniences lead many patients to abandon
Oral retinoids are effective, but their long-term
le is not as good as that of topical treatments.
treatments with topical tazarotene and oral
being tested and there are great hopes for the
of developing an enzyme replacement therapy
he topical application of transglutaminase.
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oses are a very clinically heterogeneous group of
but it has only been in recent decades that the
molecular causes have been elucidated. Sala-
s the cradle of the clinical study of ichthyosis
nd for decades researchers there have investi-
occurrence of the disease within family groups,
ven identified individuals who were unaware that
genetically related. Over 40 years ago, baptismal
the churches of the region’s towns and villages
zed to create detailed genetic trees that provided
n on the inheritance pattern of the disease. Sub-
llaboration with the genetics laboratory led by
ogelio González Sarmiento in the Department of
e at the University of Salamanca made it possi-
plete the study of many cases of patients with
hthyosis and lamellar ichthyosis that had been
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ar diagnosis, daily care of these patients was
primary concern. Before oral retinoids became
nd at a time when topical care was difficult to
Samuel and
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common d
a sense of
?r cultural and hygiene reasons, the clinical man-
f these patients was a major social problem.
underwent psychological assessment, these chil-
ified themselves in drawings as individuals with
hes on their skin, and pointed unfalteringly to
ers when they were asked who was to blame for
em. They were not, therefore, oblivious to the
ffecting their physical appearance, nor were they
the role played by genetics when they pointed to
ers as the person responsible. Despite advances
and generalized access to oral therapy, patients
osis still need our support and understanding.
Towards?the?Future:?Humanized?
f?Ichthyosis?and?other?Hyperkeratotic?
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ndo Larcher and Marcela del Río. División
dicina Epitelial, Centro de Investigaciones
as, Medioambientales y Tecnológicas,
Investigación en Red de Enfermedades
partamento de Bioingeniería, UC3M,
urrently no cures for most of the hereditary skin
enodermatosis). However, a great deal of work is
to develop effective treatments, including cell
herapies. To evaluate the efficacy and safety of
approaches in the preclinical phase we need clin-
ant models. Although transgenic mouse models
knock-out models) are very valuable tools for
ing the molecular mechanisms of disease, they
erally a reliable substitute for the human condi-
ularly in the case of skin disorders. In fact, the
histologic differences between mouse and human
murine models of skin disease relatively useless
h into therapeutic responses. The use of human-
ls is a much more reliable system. Through the
est cutaneous bioengineering methods and start-
in biopsies obtained from patients, our group has
to model several genetic skin diseases. Initially,
models of different kinds of bullous epidermol-
her genodermatoses, and more recently we have
disorders of epidermal differentiation. Using a
tion-reconstruction approach, we have created
congenital pachyonychia,3 Netherton syndrome,4
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